SUMMARY Twenty-six patients being evaluated for renovascular hypertension were studied to assess the diagnostic value of enhancing the differential between renal venous renins (PRA) by a single 25 mg oral dose of converting enzyme inhibitor (CEI, captopril). Antihypertensive medications were not discontinued prior to the study, and renal venous effluent was sampled before and 30 minutes after CEI. Eight patients without stenosis who did not have surgery had post-CEI ratios of less than 3.0. The other 18 patients had operative intervention, with 14 subsequently having improved blood pressure control. Of these 14, seven patients with unilateral stenosis, four patients with bilateral stenosis, and one patient without overt stenosis but with other evidence of reduced renal blood flow had 30-minute PRA ratios of 3.0 or greater. Five of these 14 patients had prestimulation ratios of less than 1.5 and might not be considered operative candidates by conventional criteria. Four other patients unimproved by surgery had post-CEI ratios of less than 3.0 despite a baseline ratio of greater than 1.5 in two of four. Only two patients with post-CEI ratios of less than 3.0 were improved with surgery. We conclude that a 30-minute post-CEI renal venous ratio of 3.0 or greater enhances the probability that patients with renovascular disease, and hypertension will respond to surgical intervention with improved blood pressure control. (Hypertension 5: 615-622, 1983) KEY WORDS • captopril • converting enzyme inhibitor plasma renin activity • renovascular hypertension R ENOVASCULAR hypertension constitutes less than 5% of hypertensive diseases; yet the potential for successful treatment with surgical intervention, percutaneous dilation, or specific medical management places a premium on accurate diagnosis. Unfortunately, the discovery of renal artery stenosis by angiography does not prove a functional relationship between the vascular lesion and the hypertension.
R ENOVASCULAR hypertension constitutes less than 5% of hypertensive diseases; yet the potential for successful treatment with surgical intervention, percutaneous dilation, or specific medical management places a premium on accurate diagnosis. Unfortunately, the discovery of renal artery stenosis by angiography does not prove a functional relationship between the vascular lesion and the hypertension. 1 ' 2 To clarify the functional role of the stenotic lesion, a ratio of renal venous plasma renin activity (PRA) of 1.5 or greater has been generally accepted as indicative of physiologically significant renal artery stenosis. 3 " 7 On occasion this ratio is less than 1.5, yet surgical intervention results in significant improvement in the blood pressure. Several maneuvers may increase renin production from the involved kidney and more sharply define these potentially curable patients. These include upright tilt, 8 -9 diuretic or vasodilator pretreatment,'°~1 2 and angiotensin II (All) blockade using either intravenous converting-enzyme inhibitor (CEI) 13 or saralasin. 14 " 16 In contrast, many antihypertensive medications may decrease renin production and invalidate renal venous renin ratios unless special precautions are taken to withdraw the medications prior to testing.
Captopril, an orally effective antihypertensive agent that inhibits the conversion of angiotensin I to angiotensin II, has been shown to raise plasma renin activity. The present study was designed to determine if a single dose of captopril increases renin production and lateralization and thereby enhances the diagnostic accuracy of PRA ratios in the diagnosis of renovascular hypertension.
Methods Twenty-six patients (aged 8 to 73 years) underwent renal arteriography for evaluation of hypertension. The protocol was approved under guidelines set by the 616 HYPERTENSION VOL 5, No 4, JULY-AUGUST 1983 IRB, and informed consent was obtained from each patient. Antihypertensive medications taken by the patients were not discontinued prior to the study. On six occasions 40 mg of furosemide was given orally the night before and the morning of renal venous sampling. Renal veins were sequentially catheterized with a single catheter via the Seldinger technique, and peripheral blood samples were obtained from an indwelling intravenous catheter placed in the forearm. Renal arteriography was generally performed 1 to 2 days before renal venous sampling.
Blood samples were obtained for PRA from the right and left renal veins and from the antecubital vein immediately before and 30 minutes after 25 mg of captopril was administered orally. On two occasions (Patient 15, a 53-year-old man who had recently undergone carotid endarterectomy and Patient 20, an 8-year-old boy) the captopril dose was reduced to 12.5 mg. Patients remained supine during the procedure. Blood pressure was measured using an automatic oscillometric indirect arm cuff technique (Dinamap, Inc.), and the mean blood pressure (defined as diastolic blood pressure plus one-third pulse pressure) was computed. It was predetermined that a fall in mean blood pressure of 60 mm Hg or greater would be corrected by the intravenous administration of 300 cc of isotonic saline over 5 minutes. This occurred on one occasion, with no sequelae to the patient. No sideeffects were noted in the other patients.
Plasma renin activity was determined by a previously reported technique." PRA ratios were calculated as the stenotic to nonstenotic side in those patients with unilateral anatomic disease or as the ratio of the initially high to low PRA values in those patients with bilateral disease and those without renal artery stenosis.
The patients were divided into three groups on the basis of their arteriographic studies: Additionally, three hypertensive patients with normal arteriograms (Patients 1-3) were studied as controls using the same protocol. All patients in Groups I and II subsequently underwent operative intervention. Data within each group were compared to the baseline data at zero minutes. The differences between studies and the comparisons within studies were evaluated with the unpaired and paired t test, as appropriate. A p < 0.05 was used to indicate significance. 
Results
The demographic data for each patient are displayed in tables 1 and 2. Despite a renal venous renin ratio of greater than 1.5 prior to stimulation in two of the three hypertensive control patients with normal arteriograms, the postcaptopril ratio remained less than 3.0 in all ( fig. 1) .
Seven of 11 patients with unilateral renal artery stenosis had baseline PRA ratios of the stenotic to nonstenotic side (stenotic side to periphery in Patient 4 with only a transplant kidney) greater than 1.5 prior to captopril stimulation. Eight of the 11 have been improved (defined by a 50% or greater reduction in medication to maintain the diastolic pressure below 90 mm Hg or by a decrease in the diastolic pressure of greater than 20 mm Hg after surgery while on the same medication) following surgical intervention. This improvement included two patients who had prestimulation ratios of less than 1.5 (false negatives by conventional criteria) but who had poststimulation ratios of greater than 3.0. The ratio after stimulation was greater than 3.0 in seven of the eight improved patients. In contrast, all three patients who were unimproved despite surgery had 30-minute poststimulation ratios of less than 3.0. Two of these three, Patients 9 and 13, had very low absolute PRAs, which also would decrease the likelihood of renin dependent hypertension. All patients with bilateral renal artery stenosis had postoperative improvement in their blood pressure control. Four of five underwent unilateral repair and one (Patient 15) underwent bilateral repair. In two of these patients, the initial ratios were nondiagnostic (less than 1.5) but increased to greater than 3.0 after captopril. With two others the ratio significantly increased from an already diagnostic basal value. In Patient 18, the high-to-low PRA ratio decreased after CEI, while the low-to-peripheral ratio increased. This suggests significant bilateral disease and may explain the only partial response (as opposed to cure) of the patient's hypertension with unilateral surgical intervention.
Seven patients in Group III (abnormal arteriograms but with lesions other than renal artery stenosis) had no statistically significant change in their mean renal venous ratios. The renal venous ratio following CEI remained below 3.0 in the five patients in this group who were not treated surgically. Of the two patients who were operated on, one (Patient 21) had a small left kidney and a basal renal venous ratio of greater than 1.5. This ratio decreased following CEI while the right-to-peripheral ratio increased, suggesting that the cause of the hypertension could not be localized to a single kidney. He subsequently underwent a left nephrectomy at another institution, which did not significantly improve his mild hypertension. Conversely, Patient 20 had a normal right-to-left ratio that rose with CEI stimulation. Arteriography had previously revealed an anomalous second right renal artery with a slight delay in flow to the segment associated with this vessel. Despite the absence of arteriographic narrowing, we felt this represented functional ischemia. A right heminephrectomy resulted in dramatic improvement of this patient's long-standing refractory hypertension.
Of the 26 patients, 18 have undergone surgical intervention ( fig. 2) . Four of 18 were unimproved (Patients 5, 9, 13, and 21). Three of these four had absolute PRAs of less than 10 ng/ml/hr following captopril and all four had 30-minute post-CEI renal venous PRA ratios of less than 3.0. None of these patients has been restudied to rule out a technical failure. Patients 5 and 21 had conventionally "diagnostic" ratios prior to stimulation. In contrast, all 14 improved patients had absolute stimulated PRAs of greater than 10 ng/ml/hr with a postcaptopril renin ratio of greater than 3.0 in 12 of 14. Comparison of the operated improved patients to the unoperated patients without stenosis ( fig. 3) shows no statistically significant difference in the ratio at0 minutes (4.4 ± 1.68 vs 1.8 ± 0.39,p = 0.07) but the difference is highly significant at 30 minutes (10.7 ± 2.79 vs 1.7 ± 0.26, p = 0.0014).
Renin release from the contralateral kidney can be assessed with a ratio of its renin activity to the plasma renin activity in the peripheral venous blood. In the patients in whom it could be evaluated, the mean contralateral (low) to peripheral PRA ratio after captopril was 1.1 ± 0.08 in those who were improved with surgery, with four of these 13 improved patients hav- ing contralateral (low) to peripheral ratios of less than 1.0. In contrast, this ratio was greater than 3.0 (mean 5.4 ± 1.79;/? = 0.016) in three of four patients who were not improved with surgical intervention. The mean blood pressure dropped by 23 ± 2.2 mm Hg 30 minutes after captopril in the patients who benefited with surgery, but only by 15 ± 6.5 min Hg in those who were unimproved (NS). Similarly, the decline in the mean blood pressure was only 7 ± 1.7 mm Hg in the patients without evidence of renal ischemia (Group III and angiographically normal patients).
Discussion
This study demonstrates that a single oral dose of captopril enhances the diagnostic value of PRA determinations in the evaluation of renovascular hyperten- sion. It is in agreement with the report by Re et al. 13 who used an intravenous preparation of CEI, teprotide, which is not available for clinical use. These investigators demonstrated a statistically significant increase in PRA ratios after intravenous CEI in hypertensive patients with renal disease as opposed to a nonsignificant decrease in PRA ratios in those hypertensive patients without angiographic evidence of renal artery stenosis. 13 Other stimuli advocated to enhance renin production at the time of differential renal vein studies have included upright posture 8 ' 9 and vasodilator therapy with hydralazine" or nitroprusside. 12 Captopril offers both theoretical and pragmatic advantages to these stimulatory maneuvers. CEI specifically interrupts the short loop feedback inhibition of renin release by All as well as lowers the blood pressure. The oral administration is convenient and does not require a closely monitored intravenous infusion such as for nitroprusside nor does it produce a potentially dangerous reflex tachycardia as does hydralazine. Saralasin, a competitive antagonist of All, has also been recommended as a stimulus to renin production. 14 " 16 Since saralasin has a weak All agonistic activity, its efficacy in stimulating renal vein PRA and lowering blood pressure may be reduced compared to CEI inhibition. 19 Enhancement of the diagnostic value of renal venous renin determinations by sodium depletion has been reported. 10 Such depletion may be accomplished by diuretics or by dietary means. Six of the patients in this study received a loop diuretic the evening before Although the comparisons are relatively limited, those patients receiving diuretics had higher poststimulation peripheral PR As (89.0 ± 32.64 ng/ml/hr) compared to the remainder of the group (9.6 ± 2.46 ng/ml/hr, p < 0.05). Thus, sodium restriction prior to captopril appears to enhance the response to this agent in the evaluation of renovascular hypertension. The usefulness of PRA ratios is evident despite continuation of antihypertensive medications. This observation is particularly important since discontinuation of all antihypertensive medications, often recommended because of their variable effects on renin release, may allow a significant and potentially dangerous elevation in blood pressure. Additionally, we could detect no trend in renin response to captopril depending upon antihypertensive medications (other than diuretics) being taken at the time of the study. The decrease in blood pressure following captopril is also useful for the stabilization of control during and after the procedure. If significantly better blood pressure is achieved, continued therapy with this agent in the postcatheterization period may be indicated.
The use of captopril as a stimulus for renin release appears quite effective. This method correctly predicted the blood pressure response to surgical intervention in 15 of 17 patients who underwent operative repair. A significant difference in the mean postCEI renal venous renin ratios was apparent between those improved by surgery and those who were either unimproved or those without overt angiographic renal artery stenosis. Based on this study, appropriate prognostic criteria for successful intervention should include: 1) angiographic evidence of reduced renal cortical blood flow; 2) an absolute 30-minute stimulated renin of greater than 10 ng/ml/hr; and 3) a 30-minute stimulated renal venous PRA ratio of greater than 3.0.
The contralateral (low) to peripheral PRA ratios suggest that renin release from the uninvolved or less involved kidney is in general inhibited by the high renin output from the ischemic kidney. This ratio, if less than or equal to 1.0, may thus provide useful confirmatory information in assessing which patients might best respond to unilateral surgical intervention. In contrast, we found the decline in blood pressure in response to captopril to be nonspecific and of little predictive value.
In summary, this study demonstrates that CEI mediated stimulation of renin production is a simple, safe, and orally effective adjunct to the diagnosis of renovascular hypertension. If interpreted in conjunction with angiographic findings and absolute plasma renin activities, the technique can allow detection of functionally significant lesions which are not apparent prior to stimulation. It also provides a means to detect a dominant kidney which may be responsible for hypertension in patients with bilateral disease. Additionally, CEI stimulation circumvents the need for potentially dangerous cessation of antihypertensive medications prior to study.
